Home  >  Products  >  SHMT1 (serine hydroxymethyltransferase 1 (soluble)) Blocking Peptide (the N terminal of SHMT1)(100ug)
SHMT1 (serine hydroxymethyltransferase 1 (soluble)) Blocking Peptide (the N terminal of SHMT1)(100ug)

SHMT1 (serine hydroxymethyltransferase 1 (soluble)) Blocking Peptide (the N terminal of SHMT1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SHMT1 Antibody(ARP49040_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP49040
Size: 100ug
Weight: 53kDa
Gene: 6470
Format: Lyophilized powder
Target: This gene encodes the cellular form of serine hydroxymethyltransferase, a pyridoxal phosphate-containing enzyme that catalyzes the reversible conversion of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. This reaction provides one carbon units for synthesis of methionine, thymidylate, and purines in the cytoplasm. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Alternative splicing of this gene results in 2 transcript variants encoding 2 different isoforms. Additional transcript variants have been described, but their biological validity has not been determined.
Alternative names: CSHMT; MGC15229; MGC24556; SHMT
See Full Product Listings >